期刊文献+

HPLC法测定大鼠体内尼莫地平脂肪乳中尼莫地平的含量 被引量:5

Determination of nimodipine fat emulsion injection in rats by HPLC
暂未订购
导出
摘要 目的 建立尼莫地平脂肪乳注射液的高效液相色谱分析方法,并应用于大鼠体内的药动学研究.方法 血浆样品以乙醚-正己烷(体积比1∶1)萃取,采用HPLC法进行测定分析.色谱柱为安捷伦XDB-C18柱(250 mm×4.6 mm,5μm);流动相为甲醇-水(体积比为65∶35);流速为1.0 mL·min^-1;检测波长为360 nm.结果 尼莫地平在0.1~40μg·mL-1呈现良好的线性关系(r^2=0.999 9),方法的日内、日间精密度RSD值分别在0.62%~8.8%和1.6% ~ 8.4%之间,相对回收率为85.5%~ 103.2%,绝对回收率为78.5%~91.6%,定量下限为0.1·m^L-1.大鼠注射给予尼莫地平脂肪乳注射液(2.5 mg·kg^-1)后,t1/2(β)为(19.91±4.11) min,AUC0-120为(138.63±35.70) mg·min·L-1.结论 本方法准确、简便、灵敏,可用于尼莫地平脂肪乳注射液在大鼠体内的药动学测定. Objective To establish a HPLC method for the determination of nimodipine fat emulsion injection in rat plasma, and to investigate its pharmacokinetics. Methods Plasma samples were analyzed by HPLC after liquid extraction of ether and n-hexane ( 1:1 ).The chromatographic conditions were as follows: Agilent XDB- C 18 chromatographic column; the mobile phase was methanol:water (65:35); the flow rate was 1.0 mL · min^-1; UV detection wavelength was 360 nm. Results Nimodipine had a good linear relationship when its concentration was between 0.1-40 μg · mL^-1 .The intra-day and inter-day precision of this method were 0.62% -8.8% and 1.6%-8.4%.Relative recoveries and absolute recoveries were between 85.5%-103.2% and 78.5% -91.6%.Lower limit of quantification of nimodipine was 0.1 μg · mL^-1 .Rat plasma samples were collected after a single dose of nimodipine fat emulsion injection and pharmacokinetic parameters of nimodipine were estimated,respectively.The t1/2(β) were (19.91±4.11) min and the AUCo_12o values were (138.63±35.70) mg · min · L^-1 .Conclusion The method is accurate, simple and sensitive, which can be used for the determination of serum nimodipine concentration.
出处 《广东药学院学报》 CAS 2014年第2期146-149,共4页 Academic Journal of Guangdong College of Pharmacy
基金 广东省科技计划项目(2011B031800049) 广东省教育部产学研结合项目(2011B090400164) 广州市重大科技计划项目(201300000046)
关键词 尼莫地平 脂肪乳注射剂 药动学 高效液相色谱法 nimodipine fat emulsion injection pharmacokinetics HPLC
  • 相关文献

参考文献9

二级参考文献55

共引文献73

同被引文献64

  • 1周虹,邹梅娟,史一杰,冀召帅,吴怡,程刚.磷酸川芎嗪对大鼠体内尼莫地平药动学的影响[J].中国药剂学杂志(网络版),2011(6):113-118. 被引量:3
  • 2张晓君,王东凯,韩晓.聚合物胶束作为药物传递系统的研究进展[J].中国药剂学杂志(网络版),2009(3):177-183. 被引量:18
  • 3杨冰仪,莫金垣,赖瑢,黄宝美.双工作电极-双通道胶束电动毛细管色谱电化学法同时检测4种钙通道阻滞剂[J].分析化学,2004,32(10):1304-1308. 被引量:6
  • 4吴华,朱莹,潘世芬,王鹤尧,郑文婕.人血浆中尼莫地平的LC-MS/MS法测定及其药物动力学[J].中国医药工业杂志,2008,39(1):39-41. 被引量:7
  • 5XIONG R, LU W, LI J, et al. Preparation and characterization of intravenously injectable nimodipine nanosuspension [ J ]. In- ternational Journal of Pharmaceutics, 2008, 350 ( 2 ) : 338 - 343.
  • 6KTISTIS G. FDA warns of serious harm from IV administration of nimodipine [ J ]. Reactions Weekly, 2013, 1313 ( 1 ) : 4 - 5.
  • 7KARAVAS E, KTISTIS G, XENAKIS A, et al. Effect of hydro- gen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone [ J ]. European Journal of Pharmaceutics and Biopharmaceutics, 2006, 63 ( 2 ) : 103 - 114.
  • 8ANNA K, BARTOMIEJ M, KACPER D, et al. Mesoporous drug carrier systems for enhanced delivery rate of poorly water - soluble drug: nimodipine. Journal of Porous Materials, 2015, 22 (3) : 817 -829.
  • 9ZHENG X, YANG R, TANG X, et al. Part I : characterization of solid dispersions of nimodipine prepared by hot - melt extru- sion [ J ]. DrugDevelopment and Industrial Pharmacy, 2007, 33 : 791 - 802.
  • 10MULLER R H, RADTKE M, WISSING S A. Nanostructured lipid matrices for improved microencapsulation of drugs [ J ]. International Journal of Pharrnaceutics, 2002, 242 ( 1 - 2 ) : 121 - 128.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部